Search clinical trials for: Anticoagulation with nafamostat mesilate

Total 64 results

Yonsei University
SK Chemicals Co., Ltd.

Completed

The Effect of Nafamostat Mesilate in Prolonging Filter Patency With Patients on Continuous Renal Replacement Therapy

Acute Kidney Injury

Korea, Republic of
David N. Rosenthal

Withdrawn

EXCOR® Pediatric VAD Anticoagulation IDE

Pediatric HD
Ryazan State Medical University

Completed

Hemostasis and Inflammation in COVID-19 Patients With Venous and Arterial Thrombotic Complications

Thrombosis | Venous Thromboembolism | covid19

Russian Federation
Shen Lei

Not yet recruiting

Comparison of Nafamostat and Unfractionated Heparin in RRT for Sepsis Associated AKI

Sepsis

China
University Hospital, Ghent
University Ghent

Completed

Optimisation of Anticoagulation in Patients on Nocturnal Hemodialysis

Hemodialysis | Coagulation

Belgium
Chong Kun Dang Pharmaceutical

Completed

A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia

COVID-19

Korea, Republic of
Kyungpook National University Hospital

Completed

Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy

Acute Kidney Injury
Medical University of Gdansk

Completed

HEmoFiltration With Citric Acid Anticoagulation (HEFCAA)

Acute Kidney Injury | Renal Replacement Therapy | Acute Kidney Failure | Hemofiltration

Poland
Xu Li
LanZhou University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University... and other collaborators

Not yet recruiting

Nafamostat Mesilate in the Treatment of Severe Infection-associated Coagulopathy (NMSICRCT)

Sepsis | Sepsis-induced Coagulopathy | Nafamostat Mesilate
Ensysce Biosciences
National Institute on Drug Abuse (NIDA)

Completed

Oral Nafamostat in Healthy Volunteers

Pharmacokinetics

United States
Chong Kun Dang Pharmaceutical

Completed

A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed With COVID-19 Pneumonia

COVID-19

Russian Federation
Institut Pasteur de Dakar
Ministry of Health, Senegal; Fann Hospital, Senegal; Diamniadio Children Hospital... and other collaborators

Unknown

Efficacy and Safety Evaluation of Treatment Regimens in Adult COVID-19 Patients in Senegal (SEN-CoV-Fadj)

COVID-19

Senegal
Gyeongsang National University Hospital

Unknown

Clinical Efficacy of Nafamostat Mesylate for COVID-19 Pneumonia

COVID-19 | Corona Virus Infection
Wonju Severance Christian Hospital

Enrolling by invitation

The Safety of Nafamostat Mesylate for Patients With High Risk Bleeding Undergoing Hemodialysis: A Pilot Study (Nafamostat)

Bleeding | Dialysis; Complications

Korea, Republic of
Chulalongkorn University

Completed

Immunomodulation Effect of Regional Citrate Anticoagulation in Acute Kidney Injury Requiring Continuous Renal Replacement Therapy

Acute Kidney Injury

Thailand
Free University Medical Center
Dirinco B.V.

Completed

Citrate Versus Heparin Anticoagulation in Continuous Venovenous Hemofiltration (CASH-CVVH)

Acute Kidney Injury

Netherlands
Talphera, Inc

Not yet recruiting

Nafamostat Efficacy in Phase 3 Registrational CRRT Study (NEPHRO)

Acute Kidney Injury
University of Edinburgh
University of Oxford; Latus Therapeutics; Scottish National Blood Transfusion...

Recruiting

DEFINE - Evaluating Therapies for COVID-19 (DEFINE)

COVID-19

United Kingdom
University Hospital Padova
University of Zurich; Yokohama City University

Recruiting

Efficacy of Nafamostat in Covid-19 Patients (RACONA Study) (RACONA)

COVID19

Italy
Xiaobo Yang, MD

Recruiting

Efficacy and Safety of Nafamostat Mesylate for VV-ECMO Anticoagulation

Critical Illness | Anticoagulation

China
University Hospital, Strasbourg, France

Active, not recruiting

Oral Anticoagulation in Haemodialysis Patients (AVKDIAL)

Kidney Failure, Chronic

France
US Department of Veterans Affairs

Completed

The Home INR Study (THINRS)

Atrial Fibrillation

United States, Puerto Rico
Xiaotong Hou

Not yet recruiting

Use of Nafamostat Mesilate for Anticoagulation in Patients With ECMO

Extracorporeal Membrane Oxygenation Complication

China
University Hospital, Toulouse

Completed

Anticoagulant Clinics and Vitamin K Antagonists (COMPARE)

Blood Coagulation Disorders

France
On-X Life Technologies, Inc.
Clinipace Worldwide; Avania; Acelis Connected Health; WCG IRB

Active, not recruiting

Randomized On-X Anticoagulation Trial (PROACT)

Heart Valve Disease

United States, Canada
University of Melbourne
The George Institute; The University of Queensland; The Peter Doherty Institute... and other collaborators

Recruiting

Australasian COVID-19 Trial (ASCOT) ADAptive Platform Trial (ASCOT ADAPT)

SARS-CoV-2 Infection (COVID-19)

Australia
Teva Neuroscience, Inc.

Completed

A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

Parkinson's Disease
Ensysce Biosciences
National Institute on Drug Abuse (NIDA); Quotient Sciences

Completed

Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (MPAR-101)

Pharmacokinetics

United States
University Children's Hospital Tuebingen
German Cancer Research Center; University Hospital Tuebingen; Universität Tübingen

Completed

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

Primary/Relapsed Acute Lymphoblastic Leukemia (ALL) of Childhood, Adolescents and Young Adults

Germany
University of Milano Bicocca

Recruiting

Regional Citrate Anticoagulation for RRT During V-V ECMO (CRRT ECMO)

Acute Kidney Injury | ARDS, Human

Italy
Second Affiliated Hospital, School of Medicine,...

Recruiting

Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis (ALLY)

Atrial Fibrillation | Acute Ischemic Stroke | Intracranial Atherosclerosis | Stenosis, Carotid

China
Yonsei University

Terminated

Evaluation of the Effect of Gabexate Mesilate in the Hepatocyte Protection After Liver Resection

Liver Disease

Korea, Republic of
Assiut University

Unknown

Acute Mesenteric Venous Thrombosis.. in Assiut University Hospital Management Controversies

Mesenteric Vein Thrombosis
Hubei Cancer Hospital

Enrolling by invitation

Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC

NSCLC

China
Guangzhou Institute of Respiratory Disease
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Efficacy and Safety of Apatinib as Third-line Therapy for Primary Pulmonary Lymphoepithelioid Carcinoma (Spark-AL003)

Lung Carcinoma

China
Changzhou Cancer Hospital of Soochow University

Completed

An Exploration of Apatinib Combined With S-1 in Patients With Advanced Non-small Cell Lung Cancer (EASE)

Non-small Cell Lung Cancer

China
University Hospital Center of Martinique

Completed

Comparison of Two Rhythm of Administration of Prostaglandin Gel for Induction of Labor (GELFREQ)

Labor Complication | Cervix

Martinique
Boston Scientific Corporation
University Medical Center Mainz; National PERT Consortium, Inc.

Recruiting

Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism (HI-PEITHO)

Pulmonary Embolism

United States, France, United Kingdom, Ireland, Switzerland, Germany, Netherlands, Austria, Poland
Henan Cancer Hospital

Recruiting

Camrelizumab Combined With Apatinib Mesylate

Solid Tumor

China
Chulalongkorn University

Completed

No Monitoring of Post-filter Ionized Calcium in Regional Citrate Anticoagulation

Continuous Renal Replacement Therapy | Regional Citrate Anticoagulation | Ionized Calcium

Thailand
Fox Chase Cancer Center
Novartis

Terminated

Trial of Tasigna (Nilotinib) 400 mg Twice Daily Alone or With Gleevec (Imatinib Mesylate) 400 mg Daily for Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Metastatic Disease | GIST

United States
Viracta Therapeutics, Inc.

Recruiting

A Mass Balance Study of [14C]-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers

Advanced Cancer

Spain
Tianjin Medical University Second Hospital
Jiangsu HengRui Medicine Co., Ltd.

Unknown

Treatment of Carrying TP53 Harmful Mutations

Advanced Cancer

China
Sun Yat-sen University

Not yet recruiting

Camrelizumab Combined With Apatinib in Patients With PD-1 Antagonists Resistant Recurrent/Metastatic Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Bristol-Myers Squibb

Withdrawn

Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase

Myeloid Leukemia, Chronic, Chronic-Phase

United States
Inova Health Care Services
Novartis Pharmaceuticals

Completed

New Individualized Therapy Trial for Metastatic Colorectal Cancer (NITMEC)

Colorectal Cancer | Colorectal Neoplasm

United States
Beijing Friendship Hospital

Completed

Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer

Gastric Cancer
National Cancer Institute (NCI)

Active, not recruiting

Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial Cancer

Metastatic Bladder Urothelial Carcinoma | Metastatic Renal Pelvis Urothelial Carcinoma | Metastatic Ureter Urothelial Carcinoma | Metastatic Urethral Urothelial Carcinoma | Recurrent Bladder Urothelial Carcinoma | Recurrent Renal Pelvis Urothelial Carcinoma | Recurrent Ureter Urothelial Carcinoma and other conditions

United States
Peking University Cancer Hospital & Institute

Unknown

A Study of Apatinib Combined With Temozolomide in Patients Witn Advanced Melanoma

Advanced Melanoma

China
Hospital Israelita Albert Einstein

Recruiting

Patients Undergoing Continuous Venovenous Hemodiafiltration: Effects of Increased Blood Flow

Acute Kidney Injury

Brazil

Search clinical trials for: Anticoagulation with nafamostat mesilate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations